NDC 37000-477-90 - Pepto-Bismol
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 37000-477
- Requested NDC
- 37000-477-90
- Package NDCs from labels
- 37000-477-01, 37000-477-12, 37000-477-09, 37000-477-10, 37000-477-90
- Manufacturer
- The Procter & Gamble Manufacturing Company
- Effective date
- 2023-10-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Pepto-Bismol - The Procter & Gamble Manufacturing Company | The Procter & Gamble Manufacturing Company | 2023-10-12 | HUMAN OTC DRUG LABEL |
| Pepto-Bismol - A-S Medication Solutions | A-S Medication Solutions | 2023-02-04 | HUMAN OTC DRUG LABEL |
| Pepto-Bismol - Select Corporation | Select Corporation | 2022-04-15 | HUMAN OTC DRUG LABEL |
| Pepto-Bismol - The Procter & Gamble Manufacturing Company | The Procter & Gamble Manufacturing Company | 2021-02-11 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 37000-477-01 | 2021-02-12 | Pepto-Bismol® Tablets |
| 37000-477-09 | 2021-02-12 | Pepto-Bismol® Tablets |
| 37000-477-10 | 2021-02-12 | Pepto-Bismol® Tablets |
| 37000-477-12 | 2021-02-12 | Pepto-Bismol® Tablets |
| 37000-477-24 | 2021-02-12 | Pepto-Bismol® Tablets |
| 37000-477-01 | 2021-01-29 | Pepto-Bismol® Tablets |
| 37000-477-09 | 2021-01-29 | Pepto-Bismol® Tablets |
| 37000-477-10 | 2021-01-29 | Pepto-Bismol® Tablets |
| 37000-477-12 | 2021-01-29 | Pepto-Bismol® Tablets |
| 37000-477-24 | 2021-01-29 | Pepto-Bismol® Tablets |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 37000-477-09 | EA - Each | 37000-477 | 0242e6e2-de1b-426d-afce-d5e27e0ea3b0 | 1 | 2015-10-02 |
| 37000-477-10 | EA - Each | 37000-477 | e4fa3a27-8011-4582-8a10-be0ed001120b | 1 | 2015-10-02 |
| 37000-477-12 | EA - Each | 37000-477 | de063b90-0b74-4b42-881b-efa0a8f316e6 | 1 | 2015-10-02 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Quality Choice Ultra Strength | ANTACID TABLET (CALCIUM CARBONATE) | QUALITY CHOICE (Chain drug Marketing Assoiciation) | cdac56f1-e579-4943-a24a-6564c30086d2 | 2026-10-23 | Warnings | H0G9379FGK |
| QUALITY CHOICE Regular Strength | ANTACID TABLETS (CALCIUM CARBONATE) | QUALITY CHOICE (Chain drug Marketing Assoiciation) | fce6c50d-908f-44a6-ba63-ece813f3711b | 2026-10-23 | Warnings | H0G9379FGK |
| QUALITY CHOICE Ultra Strength | ANTACID TABLETS (CALCIUM CARBONATE) | QUALITY CHOICE (Chain drug Marketing Assoiciation) | b074a885-5d10-46e4-8de9-dd9460968dad | 2026-10-23 | Warnings | H0G9379FGK |
| QUALITY CHOICE | CALCIUM CARBONATE | QUALITY CHOICE (Chain drug Marketing Assoiciation) | 9ff282fd-7623-4c9e-8faa-c51e33a7616e | 2026-10-23 | Warnings | H0G9379FGK |
| calcium antacidextra strength extra strength | CALCIUM CARBONATE | Rugby Laboratories | d761954f-940e-4833-87b7-173a921aade1 | 2026-10-23 | Warnings | H0G9379FGK |
| Rugby Cal-Gest Antacid Assorted Flavors | ANTACID TABLETS | Rugby Laboratories, Inc. | a43184c4-d225-4539-b651-4d96535f208f | 2026-10-23 | Warnings | H0G9379FGK |
| QUALITY CHOICE Regular Strength | ANTACID TABLETS (CALCIUM CARBONATE) | QUALITY CHOICE (Chain drug Marketing Assoiciation) | 667ffb59-9bff-45a7-89f0-ccfa0d841909 | 2026-10-23 | Warnings | H0G9379FGK |
| Salicylic Acid | SALICYLIC ACID | Zennova LLC | 535aa2fd-6671-0787-e063-6394a90a5799 | 2026-10-23 | Warnings | O414PZ4LPZ |
| Hero Pore Cleanser | SALICYLIC ACID | Church & Dwight Co., Inc. | 559987c0-7abe-13fc-e063-6294a90a9f27 | 2026-10-23 | Warnings | O414PZ4LPZ |
| GlyCylic | SALICYLIC ACID | The Tetra Corporation | 501d3ba9-ba42-4c1c-983b-492adaee039d | 2026-10-23 | Warnings | O414PZ4LPZ |
| Clear Eyes Triple Relief | POLYVINYL ALCOHOL AND POVIDONE AND TETRAHYDROZOLINE HYDROCHLORIDE | Prestige Brands Holdings, Inc. | 1269a1a6-843d-4d08-bb3c-c1f3d2e7080d | 2026-10-23 | Warnings | FZ989GH94E |
| Zsayro WART REMOVER | SALICYLIC ACID 40% | Guangzhou Huixue Biotechnology Co., Ltd. | 5e8d1241-3a8d-f370-e063-6394a90af31d | 2026-10-23 | Warnings | O414PZ4LPZ |
| Rokbacap WART REMOVER | SALICYLIC ACID 40% | Guangzhou Huixue Biotechnology Co., Ltd. | 5e8e12c7-4bd1-d1cc-e063-6294a90a8cf2 | 2026-10-23 | Warnings | O414PZ4LPZ |
| Frnxuc WART REMOVER | SALICYLIC ACID 40% | Guangzhou Huixue Biotechnology Co., Ltd. | 5e8e5d7a-9c1f-2a6f-e063-6394a90a5f48 | 2026-10-23 | Warnings | O414PZ4LPZ |
| Frnxuc WART REMOVER PATCHES | SALICYLIC ACID 40% | Guangzhou Huixue Biotechnology Co., Ltd. | 5e8ea54c-e7c7-5b74-e063-6394a90ab748 | 2026-10-23 | Warnings | O414PZ4LPZ |
| QUALITY CHOICE Extra Strength | ANTACID TABLETS (CALCIUM CARBONATE) | QUALITY CHOICE (Chain drug Marketing Assoiciation) | 7c948dc6-e569-46d2-8edd-59da48857e0e | 2026-10-23 | Warnings | H0G9379FGK |
| Rugby | ANTACID TABLETS | Rugby Laboratories | 9cb56bc3-7075-4f81-bd10-7e602034b7d8 | 2026-10-23 | Warnings | H0G9379FGK |
| PNV-Omega | ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID, CYANOCOBALAMIN, CALCIUM CORBONATE, FERROUS FUMARATE, POTASSIUM IODIDE, MAGNESIUM, DOCONEXENT, ICOSAPENT | Acella Pharmaceuticals, LLC | 735c5531-137f-4cee-8c68-ae121045a8ff | 2026-10-23 | Boxed warning, Adverse reactions | H0G9379FGK |
| Quality Choice Extra Strength | ANTACID TABLETS (CALCIUM CARBONATE) | QUALITY CHOICE (Chain drug Marketing Assoiciation) | 2bb8ccb6-6275-4ace-8096-ee545501df39 | 2026-10-23 | Warnings | H0G9379FGK |
| Rugby Extra Strength Assorted Berries | ANTACID TABLETS | Rugby Laboratories | b0fcfd66-276e-4741-9aee-915b6364f25c | 2026-10-23 | Warnings | H0G9379FGK |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.